Perampanel add-on for drug-resistant focal epilepsy
Author:
Affiliation:
1. Liverpool Reviews and Implementation Group, Department of Health Data Science; University of Liverpool; Liverpool UK
2. Department of Neurology; The First Affiliated Hospital, Guangxi Medical University; Nanning China
Publisher
Wiley
Subject
Pharmacology (medical)
Reference52 articles.
1. Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304;French;Neurology,2012
2. Evaluating the efficacy and safety of E2007 (perampanel) given as adjunctive therapy in subjects with refractory partial seizures www.clinicaltrials.gov/ct2/show/NCT00699972
3. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305;French;Epilepsia,2013
4. To evaluate the efficacy and safety of E2007 (perampanel) given as adjunctive therapy in subjects with refractory partial seizures www.clinicaltrials.gov/ct2/show/NCT00699582
5. Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures;Krauss;Neurology,2012
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effect of Perampanel Treatment on Immune Function and Seizure Frequency in Pediatric Epilepsy Patients;International Journal of Pharmacology;2024-06-15
2. Efficacy and safety of adjunctive perampanel treatment in pediatric patients with epilepsy aged 4–12 years: a real-world study;Journal of Neurology;2024-05-08
3. Effectiveness analysis of three-drug combination therapies for refractory focal epilepsy;Neurotherapeutics;2024-04
4. The efficacy and safety of third-generation antiseizure medications and non-invasive brain stimulation to treat refractory epilepsy: a systematic review and network meta-analysis study;Frontiers in Neurology;2024-01-09
5. What are the benefits and harms of perampanel add-on for adults with drug-resistant focal epilepsy?;Cochrane Clinical Answers;2023-07-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3